Post-treatment PSA ≤0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniques-Reference-Cited by-同舟云学术

Post-treatment PSA ≤0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniques

Published:1999-12 Issue:6 Volume:54 Page:968-971
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Critz Frank A,Williams W.Hamilton,Holladay Clinton T,Levinson A.Keith,Benton James B,Holladay David A,Schnell Frederick J,Maxa Leela S,Shrake Philip D

Publisher

Elsevier BV

Subject

Urology

Reference15 articles.

1. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer;Kupelian;Cancer J Sci Am,1997

2. Consensus Statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37: 1035–1041, 1997.

3. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer;Fukunaga-Johnson;Int J Radiat Oncol Biol Phys,1997

4. Dose escalation with 3D conformal treatment;Hanks;Int J Radiat Oncol Biol Phys,1998

5. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma;Stock;Cancer,1996

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-specific antigen nadir within 1 year of radiotherapy combined with hormone therapy predicts cancer-specific mortality and biochemical recurrence-free survival in prostate cancer patients;BMC Urology;2022-11-15

2. How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?;International Journal of Clinical Oncology;2021-10-02

3. Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control;Radiotherapy and Oncology;2021-01

4. Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients;Radiotherapy and Oncology;2020-10

5. A biochemical definition of cure after brachytherapy for prostate cancer;Radiotherapy and Oncology;2020-08